Literature DB >> 8778354

Corneal subepithelial infiltrates following photorefractive keratectomy.

L E Probst, J J Machat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778354     DOI: 10.1016/s0886-3350(96)80233-1

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


× No keyword cloud information.
  7 in total

Review 1.  Excimer laser refractive surgery.

Authors:  E E Manche; J D Carr; W W Haw; P S Hersh
Journal:  West J Med       Date:  1998-07

2.  Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2001

Review 3.  Cataract surgery and nonsteroidal antiinflammatory drugs.

Authors:  Richard S Hoffman; Rosa Braga-Mele; Kendall Donaldson; Geoffrey Emerick; Bonnie Henderson; Malik Kahook; Nick Mamalis; Kevin M Miller; Tony Realini; Neal H Shorstein; Richard K Stiverson; Barbara Wirostko
Journal:  J Cataract Refract Surg       Date:  2016-09       Impact factor: 3.351

4.  Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs.

Authors:  Keping Xu; Mark McDermott; Linda Villanueva; Rhett M Schiffman; David A Hollander
Journal:  Clin Ophthalmol       Date:  2011-02-28

5.  Bilateral corneal melting associated with topical diclofenac 0.1% after cataract surgery in a patient with Sjögren's syndrome.

Authors:  Pei-Ning Tu; Yu-Chih Hou
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

6.  [A 27-year-old man with "corneal opacity" after being injured by a branch].

Authors:  Loïc Hamon; Elias Flockerzi; Navid Ardjomand; Berthold Seitz; Loay Daas
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

7.  Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study.

Authors:  Hassan Hashemi; Seied Mohammad Reza Taheri; Akbar Fotouhi; Azita Kheiltash
Journal:  BMC Ophthalmol       Date:  2004-09-14       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.